Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Investigate Intel Earnings With This Exciting ETF

BY | ETF Database
07/20/2026 | 22 VIEWS
The week of July 20 brings an avalanche of marquee earnings reports and with the artificial intelligence (AI) trade experiencing significant retrenchment, semiconductor stocks are under duress. That could put added focus on Intel (INTC), which reports quarterly results on Thursday, July 23.Intel’s upcoming earnings update could be an ideal time for risk-aware, short-term traders to consider the Direxion Daily INTC Bull 2X ETF (LINT).  A member of Direxion’s single-stock ETF lineup, LINT attempts to deliver 200% of the daily returns of Intel stock. Analysts expect the semiconductor giant to post second-quarter earnings per share of 21 cents on sales of $14.4 billion. For tactical traders, Intel’s earnings drop could be the perfect backdrop to deploy LINT. Options market indicators imply that Intel stock could move by up to 15% following the report, which would leave plenty of room for short-term plays. “The higher implied volatility reflects uncertainty around Intel’s outlook, manufacturing progress and ability to benefit from growing AI demand. The stock has climbed more than 160% this year, although it has fallen 17% over the past month during a broader technology selloff. That strong advance leaves less room for disappointment,” reported GuruFocus.LINT Could ShineSeveral catalysts could swing shares of Intel and LINT following the earnings report, including commentary on the company’s custom ASIC efforts. Intel has earned some kudos for these efforts, but some investors have noted that the company is a late arrival to the GPU training space, meaning there’s little margin for error here. Commentary on manufacturing capacity, particularly around the 18A node, also has the potential to move the stock and LINT because one of the takeaways from Intel’s first-quarter earnings report is that the company isn’t confounded by demand issues, but rather by supply issues. “This signals that Intel’s revenue trajectory is capped by manufacturing capacity, not demand. The forecasted 34.5% gross margin, down sequentially from Q4’s 37.9%, reflects increased 18A volumes at low initial yields and product mix shift toward externally-sourced client wafers,” noted EveryTicker. “Margin pressure will likely persist until 18A yields improve and supply constraints ease in Q2 2026.” Working past supply constraints is pivotal because those issues are capping revenue. If Intel can show signs of progress on that front, the stock could notch a near-term rebound, potentially sending LINT higher. As EveryTicker pointed out, another issue to monitor is Intel’s cash burn rate, which underscores the capital intensity of the foundry model. If Intel can show it’s improving on the -$1.6 billion burn rate, the stock and LINT could benefit. For more news, information, and analysis, visit the Leveraged & Inverse Content Hub.

More Commentary

Inside LOEV: Harding Loevner's First Active ETF
BY | ETF Database
07/20/2026 | 14 VIEWS
Rate Cuts Aren't Guaranteed; Consider Preferred Stock ETF VRP
BY | ETF Database
07/20/2026 | 16 VIEWS
$100 Billion ETFs: Meet the New Class of Mega-Funds
BY | ETF Database
07/20/2026 | 51 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.